NT-Pro-Biomarker
Abstract:
Background: In the past two decades there have been major advancements in the diagnosis, treatment and prognosis of acute coronary syndromes (ACS). Biomarkers have played a crucial role in assessing the prognosis of ACS, cardiac troponins are still the biomarkers of choice; recently Amino-terminal pro-BNP (NT-pro-BNP) is suggested to be beneficial in measuring prognosis of the disease. NT-pro-BNP primarily arose as influential prognostic biomarker in numerous cardiovascular diseases most importantly heart failure. Studies have shown that NT-pro-BNP has importance in measuring prognosis of ACS patients. The objective of this study is to evaluate the association of major adverse cardiac events (MACE) that included death, heart failure,
Background: In the past two decades there have been major advancements in the diagnosis, treatment and prognosis of acute coronary syndromes (ACS). Biomarkers have played a crucial role in assessing the prognosis of ACS, cardiac troponins are still the biomarkers of choice; recently Amino-terminal pro-BNP (NT-pro-BNP) is suggested to be beneficial in measuring prognosis of the disease. NT-pro-BNP primarily arose as influential prognostic biomarker in numerous cardiovascular diseases most importantly heart failure. Studies have shown that NT-pro-BNP has importance in measuring prognosis of ACS patients. The objective of this study is to evaluate the association of major adverse cardiac events (MACE) that included death, heart failure,